Short‐Term Postoperative Depression and Anxiety in Patients with Differentiated Thyroid Carcinoma: Assessment of Potential Oncologic‐Psycho Relevance
International Journal of Endocrinology · 2024-01 · 2024 (1)
DOI: 10.1155/2024/1717119 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Endocrinology, online erschienen am 03.10.2024. Verfasst von Lin Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shandong University, Cheeloo College of Medicine, Jinan, Shandong, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Objective
To understand whether TSH suppressive therapy affect short‐term postoperative cancer‐related depression and anxiety among DTC patients. To evaluate short‐term postoperative psychological problems and its relationship with baseline parameters, fatigue, sleep quality, illness perception, and patients’ quality of life. Study Design and Methods : This was a prospective, observational, single center study. This study involved 831 TC patients who consecutively admitted to the inpatient department of hospital between 1 st June 2020 and 31 th February 2021.
Results
Mean scores of the self‐rated anxiety scale (SAS) (49.04 vs. 40.69) and self‐rated depression scale (SDS) (44.61 vs. 39.86), as well as the incidence of anxiety (41.5% vs. 22.1%) and depression (22.5% vs. 2.4%) significantly decreased 3 months after surgery. For personal and clinical characteristics, low educational background (SAS, β = 1.392; SDS, β = 1.622; and p < 0.05), without children (SAS, β = 4.068; SDS, β = 1.873, and p < 0.01), FNAC (SAS, β = −0.981; SDS, β = −2.583; and p < 0.05), and multifocal tumor (SAS, β = −1.287; SDS, β = −2.681; and p < 0.05) were the main effects for both short‐term postoperative anxiety and depression. Multiple linear regression analysis identified the serum TSH level as a significant variable associated with worse SAS (Beta = −0.695 and p = 0.043) and SDS (Beta = −3.133 and p < 0.001) scores 3 months after surgery. FT4 was independently associated with SAS scores (Beta = −0.202 and p < 0.001). Patients with middle ATA risk had a significantly higher level of SDS scores ( p = 0.033).
Conclusion
We confirmed that cancer‐related anxiety and depression among DTC patients significantly alleviated 3 months after surgery. TSH suppression therapy has profound effects on cancer‐related anxiety and depression, and the degree of anxiety and depression significantly deteriorated with the decrease of TSH level.
Autor:innen und Institutionen
- Shandong University, Cheeloo College of Medicine, Jinan, Shandong, China.
- The Second Hospital of Shandong University, Jinan, Shandong, China.
- Department of Breast and Thyroid Surgery, Shandong Provincial Hospital, Jinan, Shandong, China.
- Department of Breast Surgery, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
ORCID-Profile: Xingsong Tian
Zitieren
APA
Chen, L., Ren, N., Yang, Q., & Tian, X. (2024). Short‐Term Postoperative Depression and Anxiety in Patients with Differentiated Thyroid Carcinoma: Assessment of Potential Oncologic‐Psycho Relevance. International Journal of Endocrinology, 2024(1). https://doi.org/10.1155/2024/1717119
Vancouver
Chen L, Ren N, Yang Q, Tian X. Short‐Term Postoperative Depression and Anxiety in Patients with Differentiated Thyroid Carcinoma: Assessment of Potential Oncologic‐Psycho Relevance. International Journal of Endocrinology. 2024;2024(1). doi:10.1155/2024/1717119
BibTeX
@article{Chen2024,
author = {Chen, Lin and Ren, Ningning and Yang, Qing and Tian, Xingsong},
title = {Short‐Term Postoperative Depression and Anxiety in Patients with Differentiated Thyroid Carcinoma: Assessment of Potential Oncologic‐Psycho Relevance},
journal = {International Journal of Endocrinology},
year = {2024},
volume = {2024},
number = {1},
doi = {10.1155/2024/1717119}
}
EUVIMED